Hot Dow Dividend Companies To Own For 2016

Synchrony Financial (SYF) tumbled 13% yesterday after the credit-card issuer said it was seeing more bad loans, an announcement that also rocked Discover Financial Services (DFS), Capital One Financial (COF) and American Express (AXP). Jefferies analyst John Hecht and team call the plunge in Synchrony Financial “an attractive entry point”:

NYSE

As a reminder, prior NCO guidance was for NCOs to be consistent with 2014-2015 levels. After recently finishing its loss forecast, the company now anticipates a 20-30 bps increasing in NCOs over the next twelve months versus its prior forecast. In other words, Synchrony’s NCO guidance increased from 4.3%-4.5% for FY16 to 4.5% to 4.8% over the next twelve months. Additionally,Synchrony anticipates its ALLL will increase by a corresponding 20-30 bps versus the 1Q16 level of 5.50%.

Hot Dow Dividend Companies To Own For 2016: Enbridge Inc(ENB)

 

Enbridge Inc. operates as an energy transportation and distribution company in the United States and Canada. Its Liquids Pipelines segment operates common carrier and contract crude oil, natural gas liquids (NGL), and refined products pipelines and terminals. The companys Gas Distribution segment operates as a natural gas utility that serves residential, commercial, and industrial customers in Central and Eastern Ontario, and Northern New York State, as well as in Quebec and New Brunswick. Its Gas Pipelines, Processing and Energy Services segment has interests in natural gas pipelines, including the Vector Pipeline and transmission and gathering pipelines in the Gulf of Mexico, as well as holds an interest in Aux Sable, a natural gas fractionation and extraction facility. This segment is also involved in the renewable energy projects, such as wind, solar, and geothermal projects with a generating capacity of approximately 2, 800 MW. The companys Sponsored Investments segment is involved in renewable and alternative power generation; crude oil and liquid petroleum transportation and storage; and natural gas and NGL gathering, treating, processing, and transportation. Enbridge Inc. has a strategic partnership with EDF Group for the development, construction, and operation of three French offshore wind farms. The company was formerly known as IPL Energy Inc. and changed its name to Enbridge Inc. in October 1998. Enbridge Inc. was founded in 1949 and is headquartered in Calgary, Canada.

Advisors’ Opinion:

  • [By Callum Turcan]

    Bridging the way
    Enbridge (NYSE: ENB  ) currently carries 2.2 million barrels of crude oil and liquidseach day through its vast 15,372 thousand mile pipeline system.Enbridge has recently undergonea $6.2 billion program to grow shipping capacity in Western Canada and the Bakken by 400,000 bpd. Western Canada is home to the booming oil sands play, so Enbridge is trying to capitalize on two high-growth markets.

Hot Dow Dividend Companies To Own For 2016: eHealth Inc.(EHTH)

eHealth, Inc. offers Internet-based insurance agency services for individuals, families, and small businesses in the United States. The company also offers technology licensing and Internet advertising services. Its ecommerce platforms organize and present health insurance information in various formats, as well as enables individuals, families, and small businesses to research, analyze, compare, and purchase various health insurance plans. The company offers various medical health insurance coverage plans, such as preferred provider organization, health maintenance organization and indemnity plans, Medicare plans, short-term medical insurance, student health insurance, and health savings account eligible health insurance plans, as well as ancillary plans, such as dental, vision, and life insurance. Its customers access its ecommerce platforms through its Websites, including eHealth.com, eHealthInsurance.com, eHealthMedicare.com, and PlanPrescriber.com, as well as through a network of marketing partners. The company was incorporated in 1997 and is headquartered in Mountain View, California.

Advisors’ Opinion:

  • [By Lisa Levin]

    eHealth, Inc. (NASDAQ: EHTH) was down, falling around 32 percent to $9.53. eHealth reported a Q2 net loss of $0.5 million, versus a year-ago net income of $5.8 million. The company also reported weak quarterly revenue.

10 Best Construction Stocks To Invest In 2016: lululemon athletica inc.(LULU)

Lululemon Athletica Inc., together with its subsidiaries engages in the design, manufacture, and distribution of athletic apparel and accessories for women, men, and female youth primarily in Canada, the United States, and Australia. Its apparel assortments include fitness pants, shorts, tops, and jackets for healthy lifestyle activities, such as yoga, running, and general fitness. The company?s fitness-related accessories comprise bags, socks, underwear, yoga mats, instructional yoga DVDs, and water bottles. It sells its products through its retail stores; independent franchises; and a network of wholesale accounts, such as yoga studios, health clubs, and fitness centers, as well as directly to consumers through e-commerce. As of May 1, 2011, the company had 142 corporate-owned and franchise stores under the lululemon athletica and ivivva athletica brand names. Lululemon Athletica Inc. was founded in 1998 and is based in Vancouver, Canada.

Advisors’ Opinion:

  • [By Victor Mora]

    Lululemon provides highly-demanded athletic apparel to consumers across the nation. The company recently reported strong earnings and revenue numbers, however, investors had higher expectations. The stock has traded sideways for most of the last several years and is currently near the center of its range. Over the last four quarters, investors have expected more from the company, though earnings and revenues have been rising. Relative to its peers and sector, Lululemon has been a weak year-to-date performer. WAIT AND SEE what Lululemon does this coming quarter.

Hot Dow Dividend Companies To Own For 2016: Digital Ally Inc.(DGLY)

Digital Ally, Inc. engages in the production and sale of digital video imaging, audio/video recording, storage, and other products for use in law enforcement and security applications. Its digital audio/video recording and storage product line comprises an in-car digital audio/video system that is integrated into a rear view mirror; an all-weather mobile digital audio/video system designed for motorcycle, ATV, and boat uses; a miniature body-worn digital audio/video camera; a hand-held speed detection system based on light detection and ranging (LIDAR); a hand-held thermal imaging camera used for improved night vision; and a digital audio/video system, which is integrated into a law-enforcement style flashlight. The company?s products make self-contained video and audio recordings onto flash memory cards that are incorporated in the body of the digital video rear view mirror, officer-worn video, and audio system and flashlight. Digital Ally, Inc. sells its products to law enforcement agencies and other security organizations, as well as for consumer and commercial applications through direct sales and third-party distributors. The company is based in Overland Park, Kansas.

Advisors’ Opinion:

  • [By Lisa Levin]

    Digital Ally, Inc. (NASDAQ: DGLY) shares were also up, gaining 63 percent to $6.75 following the deadly shooting in Dallas in which five police offers were murdered by a sniper.

Hot Dow Dividend Companies To Own For 2016: Valeant Pharmaceuticals International Inc(VRX)

Valeant Pharmaceuticals International, Inc., a specialty pharmaceutical company, develops, manufactures, and markets pharmaceutical products in the areas of neurology, dermatology, and branded generics. It offers Wellbutrin XL to treat depressive disorders; Xenazine to treat chorea associated with Huntington?s disease; CeraVe to rebuild and repair skin barrier; and Kinerase, a cosmetic product. The company also provides Zovirax ointment to treat initial genital herpes; Xerese to treat recurrent herpes labialis; Elidel to treat atopic dermatitis; and Acanya and Atralin gels to treat acne vulgaris. In addition, it offers Cesamet to treat nausea and vomiting associated with cancer chemotherapy; Tiazac XC to treat hypertension and angina; Wellbutrin to treat depressive illness; Sublinox to treat insomnia; and Lodalis to treat hypercholesterolemia. Further, the company provides Cold-FX to strengthen immune system; Duromine/Metermine for weight loss; Difflam to treat sore throa ts; and Duro-Tuss and Rikodeine to treat dry and chesty cough, as well as various branded generics for treatments, including antibiotics, treatments for cardiovascular and neurological diseases, antifungal medications, and diabetic therapies. Additionally, it offers Bisocard to treat hypertension and angina pectoris; Flucinar, a corticosteroid ointment; and Sachol mouth ulcer gel; Bedoyecta to treat neurotic pain; M.V.I., a hospital dietary supplement for trauma and burns; Tandene to treat fever and headache; Melleril to treat anxiety and depression; and products for therapeutic classes, such as vitamin deficiency, antibacterials, and dermatology. It markets its products in the United States, Canada, Australia, New Zealand, Europe, Latin America, southeast Asia, and South Africa. The company was formerly known as Biovail Corporation and changed its name to Valeant Pharmaceuticals International, Inc. in September 2010. The company was founded in 1960 and is headquartered in M ississauga, Canada.

Advisors’ Opinion:

  • [By Monica Gerson]

    Analysts are expecting Valeant Pharmaceuticals Intl Inc (NYSE: VRX) to have earned $2.61 per share on revenue of $2.75 billion in the latest quarter. Valeant Pharmaceuticals shares gained 0.80 percent to $69.59 in after-hours trading.

  • [By Ben Levisohn]

    Morgan Stanley’s David Risinger and team give their thoughts on one of the most pressing questions for investors in shares of Valeant Pharmaceuticals International (VRX)–when will it be safe to invest? The answer is unclear:

  • [By Ben Levisohn]

    Deutsche Bank’s Gregg Gilbert and team wonder what the “new” Valeant Pharmaceuticals International (VRX) might look like–and how it will get there:

  • [By Ben Levisohn]

    Guggenheim’s Louise Chen and team argue that oral Relistor, which helps relieve constipation caused by the use of opioids, could be a $1 billion opportunity for Valeant Pharmaceuticals International (VRX):